Atogepant Preferred Over Topiramate in New Migraine Study

When comparing the tolerability, safety, and effectiveness of atogepant to the highest tolerated dose of topiramate in adult patients with a history of four or more migraine days per month.

Discovery Park Startup Showcase Sparks Entrepreneurial Energy at London Biotechnology Show 2025

The Discovery Park Startup Showcase took centre stage at the London Biotechnology Show 2025, sparking dynamic conversations and real-time feedback between emerging biotech entrepreneurs and seasoned investors.

Welcure Expands Global Sourcing With Strategic Thai Partnership

Welcure Drugs & Pharmaceuticals announced on Wednesday that it has finalized a contract with Thailand-based Fortune Sagar Impex Compamy for third-party sourcing and procurement services totaling Rs 517 cr

Boehringer Ingelheim launches three-in-one poultry vaccine in India

Boehringer Ingelheim, a global leader in animal health, has announced the launch of its latest poultry vaccine in India—a single-dose, next-generation solution that provides protection against Bursal, Newcastle and Marek’s disease...

New export push: DGFT opens 'Source from India' to more exporters

In a significant step toward strengthening India’s pharmaceutical and trade export ecosystem, the Directorate General of Foreign Trade (DGFT), Ministry of Commerce and Industry, has announced the launch of the ‘Source from India’ feature...

Application Date Extended for 11 APIs Under PLI Scheme

The Department of Pharmaceuticals (DoP) has clarified that they extended the application period for the most recent PLI scheme round for bulk drugs, from June 14 to July 4, 2025...

Lupin signs deal with China's SUP for Tiotropium DPI rollout

Pharmaceutical company Lupin Ltd announced that it has entered into a licensing and supply agreement with China's Sino Universal Pharmaceuticals (SUP) for marketing Tiotropium dry...

Innovation on Display: London Biotechnology Show 2025 Returns in 2 days

In just two days, the second edition of the London Biotechnology Show (LBS) returns to ExCeL London on 18–19 June, bringing together one of the most influential gatherings in the global biotechnology calendar. The event promises cutting-edge science

DBT Invites Proposals for Green Biomanufacturing of APIs & Chemicals

Under its BioE3 (Biotechnology for Economy, Environment, and Employment) policy, which aims to promote high-performance biomanufacturing, the Department of Biotechnology (DBT) intends to support the biomanufacturing of active pharmaceutical

Sigachi Expands API Capacity with New Orvakal Facility, Grows Globally

An International Leader in Pharmaceutical Excipients Kolkata, 13 June 2025: The biggest manufacturer of microcrystalline cellulose (MCC) in India, Sigachi Industries Ltd., is steadily raising the bar for pharmaceutical excipients

© 2025 India Pharma Outlook. All Rights Reserved.

Safety Monitoring